Overview


According to FutureWise analysis the market for Acid Citrate Dextrose Tubes in 2023 is US$ 0.51 billion, and is expected to reach US$ 0.76 billion by 2031 at a CAGR of 5.20%.

Acid Citrate Dextrose (ACD), also known as Solution A, is the anticoagulant citrate dextrose solution is used as an anticoagulant for the collection, storage, and transportation of whole blood and blood components for various purposes, including diagnostic testing, blood transfusions, and research applications. ACD tubes are available in glass only and are identifiable by a yellow cap. ACD tubes contain the active anticoagulant Trisodium Citrate with Citric Acid and Dextrose. Vacutainer tubes containing Acid Citrate Dextrose (ACD) are used for blood bank, clinics, hospitals and research laboratories.

Acid citrate reactions or toxicity may occur with the infusion and return of blood containing acid citrate anticoagulant. The recipient of the blood containing acid citrate dextrose should be monitored for the symptoms of citrate reaction. The signs and symptoms of citrate reaction begin with paresthesia, a "tingling" feeling around the mouth or extremities, followed by severe reactions indicated by hypotension and possible cardiac arrhythmia. Citrate toxicity may occur more frequently in hypothermic individuals with impaired liver or renal function or lower calcium levels because of an underlying condition.

FutureWise Market Research has published a report that provides an insightful acid citrate dextrose tubes market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, acid citrate dextrose tubes market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Fisher Scientific
  • Becton Dickinson
  • Biomet, Inc.
  • Greiner Bio-One International GmbH
  • Cepham Life Sciences
  • Sekisui Medical Co., Ltd
  • Medtronic Plc

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Acid Citrate Dextrose Tubes Market:

  • In May 2022- Babson Diagnostics and Becton, Dickinson and Company are expanding their partnership to enable individuals to collect blood samples at home for diagnostic testing, benefiting the acid citrate dextrose tubes market by simplifying blood testing procedures.
  • In March 2021- Becton Dickinson & Company has revealed its acquisition of GSL Solutions, Inc., a company specializing in intelligent medication solutions to address substance shortages and individualized patient-specific treatments, thereby improving medical storage security and compliance. This acquisition holds the potential to advance acid-citrate dextrose tubes and expand the market's scope.

Growing prevalence of chronic disorders such as respiratory disorders, diabetes, and cardiovascular diseases is expected to anticipate the growth of the market. These diseases require regular monitoring, diagnostic testing, and therapeutic interventions, and all these rely on accurate and efficient blood collection and analysis. ACD tubes provide a reliable method for anticoagulation, ensuring the integrity of blood samples for diagnostic purposes, as well as facilitating research activities aimed at understanding and developing treatments for these chronic diseases. Furthermore, the high cost of ACD tubes can pose significant constraints in developing regions. The higher cost of ACD tubes compared to alternative anticoagulant tubes may limit their adoption or restrict the use of specific applications or healthcare facilities. Cost-effective alternatives to minimize the financial burden associated with ACD tubes, such as bulk purchasing, local manufacturing, or government subsidies, may be explored to ensure their accessibility and affordability in developing regions.

By Type

  • 6.0 ML
  • 8.5 ML

By Application

  • Hospitals
  • Diagnostics Centers
  • Health Care Clinics

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Due to the growth of the market is attributed to the rising awareness of safe blood storage, blood transfusion, a rise in the geriatric population, and better health care standards. These regions have better reach to technological advancements and can invest resources in procuring the best healthcare solutions. Also, the presence of key market players in the region is expected to be another salient feature driving the regional market during the forecast period.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Acid Citrate Dextrose Tubes Market By Type, By Application, and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt. 
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Acid Citrate Dextrose Tubes Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Acid Citrate Dextrose Tubes Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Acid Citrate Dextrose Tubes Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Acid Citrate Dextrose Tubes Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. 6.0 . ML
        2. 8.5 . ML

  • 8.   Acid Citrate Dextrose Tubes Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Diagnostics Centers
        3. Health Care Clinics

  • 9.   North America Acid Citrate Dextrose Tubes Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Acid Citrate Dextrose Tubes Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Acid Citrate Dextrose Tubes Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Acid Citrate Dextrose Tubes Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Acid Citrate Dextrose Tubes Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Fisher Scientific
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Becton Dickinson
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Biomet, Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Greiner Bio-One International GmbH
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Cepham Life Sciences
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Sekisui Medical Co., Ltd
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Medtronic Plc
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients